883762d6 5d17 4ccd 99e6 254a6ad208ef 01
Grisofulvin Suspension
Product Images NDC 69097-361
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Grisofulvin (NDC 69097-361). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Cipla Usa Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
883762d6 5d17 4ccd 99e6 254a6ad208ef 02
NDC 69097-361 -08 is a prescription medicine used to treat various fungal infections. It comes in an oral suspension form and has a recommended adult dosage of four teaspoonfuls (500mg) daily. For children, the dosage is between one (125mg) to four (500mg) teaspoonfuls daily, depending on their age and weight. This product must be stored at 20°C to 25°C, and dispensed in a tight, light-resistant container with a child-resistant closure. It is crucial to keep this medication away from children. The active ingredient in each 5mL (one teaspoonful) of the suspension is griseofulvin USP (microsize). This medication is made by Cipla and protected by a tamper-resistant seal to ensure its safety.*
* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.
